SGL Investment Advisors Inc. Buys New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SGL Investment Advisors Inc. bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 410 shares of the medical equipment provider’s stock, valued at approximately $214,000.

Other large investors also recently modified their holdings of the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Parvin Asset Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth about $26,000. Finally, BankPlus Trust Department acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $28,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 1.0%

Shares of Intuitive Surgical stock opened at $560.28 on Friday. The company’s 50-day moving average price is $503.82 and its 200-day moving average price is $536.13. The company has a market cap of $200.81 billion, a price-to-earnings ratio of 87.41, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12-month low of $393.98 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the prior year, the company posted $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have commented on ISRG shares. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Barclays decreased their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Finally, Royal Bank of Canada cut their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $598.95.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,680 shares of company stock worth $16,854,345 in the last ninety days. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.